OTC FILING WATCH · LIVEOfficial-source OTC filing intelligence
FILING INTELLIGENCE · SOURCE: SEC EDGAR

Oncotelic Therapeutics, Inc. (OTLC)

S-1/AIssuer profile

Business summary

Official filing overview: We are a clinical-stage biopharmaceutical company developing drugs for the treatment of orphan oncology indications, developing antisense and small molecule injectable drugs for the treatment of cancer.

Filing path

Registration amendment. Watch for amendment terms, EFFECT or 424B filings

Timeline

  1. Filed: 12/22/2025, 00:00:00
  2. Capture status: 7/30/2026, 13:54:37
  3. Source: SEC EDGAR

Verify all material terms in the official source document.

Open official filing →Issuer profileLive feed